Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Fig. 2

Representative images of 5hmC immunoreactivity in malignant and non-malignant prostate tissue samples. a TMA core containing both malignant and NM prostate glands, illustrating reduced 5hmC levels in malignant (IHC score = 1, arrowheads) compared to NM glands (IHC score = 2, arrows). b Strong 5hmC staining in a malignant core (IHC score = 2). c Moderate 5hmC staining in a malignant core (IHC score = 1). d Weak 5hmC staining in malignant core (IHC score = 0)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us